NCT02058966View on ClinicalTrials.gov

Pilot Study of Entacapone for Methamphetamine Abuse

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Methamphetamine Dependence
Interventions
DRUG

Entacapone

Entacapone 200 mg oral dose

DRUG

Methamphetamine

Methamphetamine 20 mg oral dose

DRUG

Placebo

capsules compounded to be of similar appearance to the active drugs

Trial Locations (1)

97239

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Portland VA Medical Center

FED

lead

Oregon Health and Science University

OTHER

NCT02058966 - Pilot Study of Entacapone for Methamphetamine Abuse | Biotech Hunter | Biotech Hunter